510(k) Report

510(k) · Cleared

Cleared

Exofin Fusion Skin Closure System

K171442510(k) AbbreviatedCleared Sep 25, 2017132-day reviewClass II21 CFR 878.4011

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Chemence Medical, Inc. · OMD Cutaneous Tissue Adhesive With Mesh

Cleared on Sep 25, 2017 as substantially equivalent to K133864 (ETHICON, Inc., 2014) and 1 other predicate after a 132-day review. Its family tree reaches back 2 generations to 2010. 2 later devices descend from it.

Decided
Sep 25, 2017
Review
132 days
Class
Class II
Product code
OMD
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to DEN090005 (2010). 2 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2020: 1 descendant cleared2022: 1 descendant clearedDEN090005 · Prineo Skin Closure System · Closure Medical Corp. · 2010K133864 · Dermabond Prineo Skin Closure System · ETHICON, Inc. · 2014 · recalled2010201520202025
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 1 descendant K133864 · Dermabond Prineo Skin Closure System · ETHICON, Inc. · 2014 · recalledDEN090005 · Prineo Skin Closure System · Closure Medical Corp. · 20100
  1. Root · 2 generations backDEN090005 Prineo Skin Closure SystemClosure Medical Corp. · 2010
  2. 1 generation backK133864 Dermabond Prineo Skin Closure SystemETHICON, Inc. · 2014 · Recalled
  3. This deviceK171442 Exofin Fusion Skin Closure SystemChemence Medical, Inc. · 2017
  4. Descendant · cites it directly · 1 of its ownK191461 Exofin Fusion Skin Closure SystemChemence Medical, Inc. · 2020
  5. Descendant · 2 generations on · 0 of its ownK211878 LiquiBand XLAdvanced Medical Solutions Limited · 2022

Most influential descendants

Showing 2 of 2 · See all
  • K191461Exofin Fusion Skin Closure SystemChemence Medical, Inc. · 2020 · cites it directly1descendant
  • K211878LiquiBand XLAdvanced Medical Solutions Limited · 2022 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2DEN090005Prineo Skin Closure SystemClosure Medical Corp.2010—
−1K133864Dermabond Prineo Skin Closure SystemETHICON, Inc.20141
0 (this device)K171442Exofin Fusion Skin Closure SystemChemence Medical, Inc.2017—
+1K191461Exofin Fusion Skin Closure SystemChemence Medical, Inc.2020—
+2K211878LiquiBand XLAdvanced Medical Solutions Limited2022—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202010
202210
FIG. 1 — Lineage of K171442, 2010–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in OMD? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new OMD device

  1. #1 K233460 CM00622 LINC Skin Closure System (CM00622 LINC)score 8.0 · 2 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K133864Dermabond Prineo Skin Closure System
Summary page 4
…3. Predicate Device Legally marketed device to which equivalence is claimed: Device Name: Dermabond™ Prineo™ Skin Closure System 510(k) Clearance: K133864 and K082289 K171442…
ETHICON, Inc.20141
*DEN090005Prineo Skin Closure System
Our reading of the summary gave K082289, which is not in FDA’s 510(k) list. The device the summary names is FDA’s De Novo DEN090005, Prineo Skin Closure System (Closure Medical Corp.), granted Apr 30, 2010; older De Novo requests were first filed under a 510(k) number, so this links to the grant.
Closure Medical Corp.2010—

Also cleared against K133864: 5 other devices →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K191461Exofin Fusion Skin Closure SystemChemence Medical, Inc.20201

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 7 years and passes through 3 companies; a new generation was cleared every 3.9 years on median.
  • 1 of the 2 ancestors has a recall of any class.
  • Of its descendants, K191461 (Chemence Medical, Inc., 2020) has gone furthest, with 1 descendant of its own.
  • 5 other devices also cite its predicate K133864.

How does its category compare?

All OMD devices

OMD Cutaneous Tissue Adhesive With Mesh: FDA decisions, review times, recalls and adverse event reports over 20 years. 2017, this device’s year, is highlighted.

FDA decisions per year · OMD

1in 2024

2010: 12014: 12015: 12017: 22020: 12021: 12022: 12024: 1
2007high 2 (2017) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · OMD

Too few OMD 510(k)s in any year since 2007 to give a median.

Recalls per year · OMD

No recall names OMD since 2007.

Adverse event reports per year · OMD

288in 2025

2012: 252013: 542014: 172015: 942016: 1252017: 1632018: 2062019: 1532020: 862021: 1862022: 1752023: 1712024: 2562025: 288
2007high 288 (2025) · low 0 (2007)2025

MAUDE reports naming product code OMD, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20101—00
20110—00
20120—025
20130—054
20141—017
20151—094
20160—0125
20172—0163
20180—0206
20190—0153
20201—086
20211—0186
20221—0175
20230—0171
20241—0256
20250—0288
20260—0—

What is it indicated for?

Exofin Fusion Skin Closure System is intended for topical application only to hold closed easily approximated skin edges of wounds from surgical incisions, including punctures from minimally invasive surgery, and simple, thoroughly cleansed, trauma-induced lacerations. Exofin Fusion Skin Closure System should be used in conjunction with, but not in place of, deep dermal stitches. Additionally, the adjunct wound closure device component maintains temporary skin edge alignment along the length of the wound during application of the liquid adhesive.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K171442: Exofin Fusion Skin Closure System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K171442

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026